[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ptau-a-42-ratio":3},{"name":4,"total":5,"recruiting":5,"trials":6},"pTau\u002FAβ42 ratio",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04500847","Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD",[11],"Phase 1","RECRUITING","2026-08-26T02:19:27.519777Z","2026-05-05T02:43:27.760472Z"]